placebo metered dose inhaler

DRUG2 trials

Sponsors

Boehringer Ingelheim, University of Saskatchewan

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 3

Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02172469

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2001-05-31Updated: 2014-06-24

Phase 4

Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma

CompletedNCT04167280

University of SaskatchewanAsthma

Start: 2019-11-05End: 2020-03-13Updated: 2020-03-26